Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
FTAI Aviation
FTAI
$22.2B
| $177K | ﹤0.01% |
13,646
-24,997
| -65% | -$325K |
|
|
SSY
3177
DELISTED
SunLink Health Systems
SSY
| $176K | ﹤0.01% |
155,800
+4,900
| +3% | +$7.04K |
|
|
CFRX
3178
DELISTED
ContraFect Corporation
CFRX
| $176K | ﹤0.01% |
615
+186
| +43% | +$62.6K |
|
3179
Genworth Financial
GNW
$3.77B
| $175K | ﹤0.01% |
39,806
-524,594
| -93% | -$2.19M |
|
|
UFAB
3180
DELISTED
Unique Fabricating, Inc.
UFAB
| $174K | ﹤0.01% |
60,199
+6,300
| +12% | +$17.3K |
|
|
CBMB
3181
DELISTED
CBM Bancorp, Inc.
CBMB
| $174K | ﹤0.01% |
+12,400
| New | +$171K |
|
|
AVGR
3182
DELISTED
Avinger, Inc. Common Stock
AVGR
| $173K | ﹤0.01% |
695
+148
| +27% | +$77.1K |
|
|
NCNA
3183
NuCana
NCNA
$6.16M
| $172K | ﹤0.01% |
+5
| New | +$220K |
|
3184
Akebia Therapeutics
AKBA
$241M
| $170K | ﹤0.01% |
+43,427
| New | +$186K |
|
3185
US Global Investors
GROW
$38.8M
| $170K | ﹤0.01% |
+85,526
| New | +$163K |
|
|
DESP
3186
DELISTED
Despegar.com
DESP
| $168K | ﹤0.01% |
14,802
-21,898
| -60% | -$265K |
|
3187
Dogness International Corp
DOGZ
$17.7M
| $168K | ﹤0.01% |
+3,383
| New | +$189K |
|
3188
Dare Bioscience
DARE
$20.5M
| $166K | ﹤0.01% |
17,717
-570
| -3% | -$5.45K |
|
|
PLYA
3189
DELISTED
Playa Hotels & Resorts
PLYA
| $166K | ﹤0.01% |
21,200
-125,700
| -86% | -$962K |
|
3190
Palisade Bio
PALI
$375M
| $165K | ﹤0.01% |
22
+20
| +1,000% | +$279K |
|
3191
NextDecade
NEXT
$1.8B
| $164K | ﹤0.01% |
28,400
-1,700
| -6% | -$9.13K |
|
3192
Socket Mobile
SCKT
$11.2M
| $164K | ﹤0.01% |
69,640
+8,421
| +14% | +$20.1K |
|
|
XNET
3193
Xunlei
XNET
$328M
| $164K | ﹤0.01% |
71,700
+14,900
| +26% | +$37K |
|
3194
Myomo
MYO
$57.8M
| $163K | ﹤0.01% |
8,813
+2,517
| +40% | +$57.3K |
|
|
JNCE
3195
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $163K | ﹤0.01% |
48,908
+37,308
| +322% | +$149K |
|
3196
Ranger Energy Services
RNGR
$405M
| $161K | ﹤0.01% |
24,986
+10,186
| +69% | +$68.9K |
|
|
LL
3197
DELISTED
LL Flooring Holdings, Inc.
LL
| $160K | ﹤0.01% |
16,200
-551,600
| -97% | -$5.41M |
|
|
ZNB
3198
Zeta Network Group
ZNB
$2.27M
| – | – |
0
| – | – |
|
|
BVSN
3199
DELISTED
Broadvision Inc Com
BVSN
| $159K | ﹤0.01% |
86,000
+400
| +0.5% | +$561 |
|
3200
SIFCO Industries
SIF
$121M
| $157K | ﹤0.01% |
58,100
+2,300
| +4% | +$6.51K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.